Interstitial Lung Diseases in the Veterans Administration

Sponsor

Robert Tighe (U.S. Fed)

Overall Status

Active, not recruiting

CT.gov ID

NCT02479126

Collaborator

Durham VA Medical Center (U.S. Fed), Boehringer Ingelheim (Industry)

3,000

Enrollment

Location

Duration (Months)

36.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

Condition or Disease	Intervention/Treatment	Phase
Interstitial Lung Disease

Study Design

Study Type:

Observational

Anticipated Enrollment :

3000 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes

Study Start Date :

Jul 1, 2016

Anticipated Primary Completion Date :

Nov 1, 2022

Anticipated Study Completion Date :

Jun 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Interstitial Lung Disease Patients will be identified from a specified 5 year period based on an International Classification of Diseases-9 (ICD-9) code diagnosis of Interstitial Lung disease (515) or Idiopathic Pulmonary Fibrosis (516.3). The patients will be obtained from the records of the Veterans Integrated Service Network (VISN) 6: VA Mid-Atlantic Health Care Network.

Outcome Measures

Primary Outcome Measures

Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population [up to 5 years]
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population [up to 5 years]

Secondary Outcome Measures

Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease [up to 5 years]
Will compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology
Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider [up to 5 years]
Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease [up to five years]
Compare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population